Related Experiment Video
Updated: Mar 28, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
When Oncogenic Signaling Meets Sex-Biased Immune Evasion
Xue Li1,2
1Department of Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Cedars-Sinai Health Sciences University, Los Angeles, California.
Abstract:
Sex differences in tumor immunity are increasingly recognized as important determinants of cancer progression and therapeutic response. In a recent publication, Abdelfattah and colleagues identify a male-biased Yes-associated protein 1 (Yap1)-Cd276 regulatory axis that promotes immune evasion in sonic hedgehog (SHH)-induced medulloblastoma. Although Yap1 regulates tumor immune cell infiltration and immunosuppression in both sexes, disruption of this pathway confers survival benefit only in males, but not females. These findings highlight how oncogenic signaling intersects with tumor immunity and underscore the importance of considering biological sex in studies of cancer immunology and immunotherapy.
Insights
Researchers found a male-specific pathway involving Yap1-Cd276 that helps medulloblastoma evade the immune system. This discovery highlights the importance of sex differences in cancer immunology and developing targeted immunotherapies.
Area of Science:
- Oncology
- Immunology
- Genetics
Background:
- Sex differences significantly impact cancer progression and treatment outcomes.
- Understanding immune evasion mechanisms is crucial for effective cancer therapies.
Purpose of the Study:
- To investigate the role of the Yap1-Cd276 axis in sonic hedgehog-induced medulloblastoma (SHH-MB).
- To determine if sex influences the pathway's effect on tumor immunity and therapeutic response.
Main Methods:
- Analysis of the Yap1-Cd276 regulatory axis in SHH-MB models.
- Assessment of tumor immune cell infiltration and immunosuppression.
- Evaluation of pathway disruption effects on survival in both male and female subjects.
Main Results:
- A male-biased Yap1-Cd276 regulatory axis was identified in SHH-MB.
- This axis promotes immune evasion in a sex-specific manner.
- Disrupting the pathway improved survival exclusively in males, not females.
Conclusions:
- The Yap1-Cd276 pathway plays a critical role in male-specific immune evasion in SHH-MB.
- Oncogenic signaling intersects with tumor immunity differently based on biological sex.
- Future cancer immunology and immunotherapy studies must account for sex-based variations.
More Related Videos
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

